Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study - Mahajan, Ujwal Mukund; Oehrle, Bettina; Goni, Elisabetta; Strobel, Oliver; Kaiser, Jörg; Grützmann, Robert; Werner, Jens; Friess, Helmut; Gress, Thomas M; Seufferlein, Thomas W; Uhl, Waldemar; Will, Uwe; et al. (The lancet. Gastroenterology & Hepatology, 2025)
Online verfügbar: 16. Mai 2025, Artikelversion: 4. Juni 2025